Daewoong to Begin Trial of COVID-19 Stem Cell Treatment in Indonesia

Daewoong Pharmaceuticals to conduct the phase 1 of clinical trials for the COVID-19 respiratory symptom treatment using mesenchymal stem cells in Indonesia.

Daewoong Pharmaceutical, a South Korean bioengineering company, stated on Monday that it would conduct phase 1 of clinical trials for ...

Celltrion's antiviral treatment candidate CT-P59 for COVID-19 lowered the amount of SARS-CoV-2 virus in infected ferrets by 100 times.

Celltrion’s CT-P59 Antiviral Candidate Reduces COVID-19 Virus 100-Fold

by James Jung

June 1, 2020

0

Celltrion announced on Monday that its antiviral treatment candidate CT-P59 for COVID-19 positively lowered the amount of SARS-CoV-2 virus in ...

Samsung Biologics signed with Vir Biotechnology a manufacturing agreement worth approximately $362 million to mass-produce COVID-19 treatment.

Samsung Biologics Inks Deal to Mass-Produce COVID-19 Treatment

by James Jung

April 9, 2020

0

Samsung Biologics announced on Thursday that it signed with Vir Biotechnology Inc. a manufacturing agreement worth approximately $362 million (438 ...

Samsung Biologics, Aprinoia Inks Deal to Develop Alzheimer’s Treatment

by KoreaTechToday Editor

March 17, 2020

0

Samsung Biologics announced on Tuesday that it signed a contract with Aprinoia Therapeutics to develop the Taiwan-based biotech firm's Alzheimer's ...

Samsung Biologics Prepares for Budding Alzheimer’s Treatment Deals

by James Jung

January 17, 2020

0

CEO of Samsung Biologics Kim Tae-han said on Wednesday that he expects the company to take on contract deals for ...

Tag: treatment